{"id":714746,"date":"2026-02-05T17:58:59","date_gmt":"2026-02-05T15:58:59","guid":{"rendered":"https:\/\/eba.com.ua\/?p=714746"},"modified":"2026-03-12T17:25:09","modified_gmt":"2026-03-12T15:25:09","slug":"priorytety-rozvytku-farmatsevtychnogo-rynku-ta-klinichnyh-doslidzhen-v-ukrayini-zustrich-pravlinnya-komitetu-z-ohorony-zdorov-ya-z-kerivnytstvom-moz","status":"publish","type":"post","link":"https:\/\/eba.com.ua\/en\/priorytety-rozvytku-farmatsevtychnogo-rynku-ta-klinichnyh-doslidzhen-v-ukrayini-zustrich-pravlinnya-komitetu-z-ohorony-zdorov-ya-z-kerivnytstvom-moz\/","title":{"rendered":"[:ua]\u041f\u0440\u0456\u043e\u0440\u0438\u0442\u0435\u0442\u0438 \u0440\u043e\u0437\u0432\u0438\u0442\u043a\u0443 \u0444\u0430\u0440\u043c\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u043d\u043e\u0433\u043e \u0440\u0438\u043d\u043a\u0443 \u0442\u0430 \u043a\u043b\u0456\u043d\u0456\u0447\u043d\u0438\u0445 \u0434\u043e\u0441\u043b\u0456\u0434\u0436\u0435\u043d\u044c \u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0456: \u0437\u0443\u0441\u0442\u0440\u0456\u0447 \u041f\u0440\u0430\u0432\u043b\u0456\u043d\u043d\u044f \u041a\u043e\u043c\u0456\u0442\u0435\u0442\u0443 \u0437 \u043e\u0445\u043e\u0440\u043e\u043d\u0438 \u0437\u0434\u043e\u0440\u043e\u0432\u2019\u044f \u0437 \u043a\u0435\u0440\u0456\u0432\u043d\u0438\u0446\u0442\u0432\u043e\u043c \u041c\u041e\u0417\u00a0[:en]Development priorities for the pharmaceutical market and clinical trials in Ukraine: meeting of the Health Care Committee Board with the leadership of the Ministry of Health[:]"},"content":{"rendered":"<p><\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"alignnone wp-image-714747 size-full\" src=\"https:\/\/eba.com.ua\/wp-content\/uploads\/2026\/02\/WhatsApp-Image-2026-02-05-at-15.50.23.jpeg\" alt=\"\" width=\"1600\" height=\"1200\" srcset=\"https:\/\/eba.com.ua\/wp-content\/uploads\/2026\/02\/WhatsApp-Image-2026-02-05-at-15.50.23.jpeg 1600w, https:\/\/eba.com.ua\/wp-content\/uploads\/2026\/02\/WhatsApp-Image-2026-02-05-at-15.50.23-300x225.jpeg 300w, https:\/\/eba.com.ua\/wp-content\/uploads\/2026\/02\/WhatsApp-Image-2026-02-05-at-15.50.23-1024x768.jpeg 1024w, https:\/\/eba.com.ua\/wp-content\/uploads\/2026\/02\/WhatsApp-Image-2026-02-05-at-15.50.23-768x576.jpeg 768w, https:\/\/eba.com.ua\/wp-content\/uploads\/2026\/02\/WhatsApp-Image-2026-02-05-at-15.50.23-1536x1152.jpeg 1536w, https:\/\/eba.com.ua\/wp-content\/uploads\/2026\/02\/WhatsApp-Image-2026-02-05-at-15.50.23-650x488.jpeg 650w, https:\/\/eba.com.ua\/wp-content\/uploads\/2026\/02\/WhatsApp-Image-2026-02-05-at-15.50.23-600x450.jpeg 600w, https:\/\/eba.com.ua\/wp-content\/uploads\/2026\/02\/WhatsApp-Image-2026-02-05-at-15.50.23-800x600.jpeg 800w, https:\/\/eba.com.ua\/wp-content\/uploads\/2026\/02\/WhatsApp-Image-2026-02-05-at-15.50.23-100x75.jpeg 100w\" sizes=\"(max-width: 1600px) 100vw, 1600px\" \/>On 5 February, representatives of the <span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">European Business Association<\/span><\/span> met with <span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Viktor Liashko<\/span><\/span>, Minister of Health of Ukraine; Edem Adamanov, newly appointed Director of the State Expert Centre of the Ministry of Health of Ukraine; <span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Volodymyr Korolenko<\/span><\/span>, Acting Head of the State Service of Ukraine on Medicines and Drugs Control; and their colleagues.<\/p>\n<p data-start=\"592\" data-end=\"816\">The meeting was attended by Anna Bezruk, Manager of the Association\u2019s Health Care Committee; Iryna Mahdik, Executive Director of the Clinical Trials Subcommittee; and members of the Boards of the Committee and Subcommittee.<\/p>\n<p data-start=\"818\" data-end=\"1108\">During the meeting, representatives of the EBA discussed with the heads of the relevant authorities and their teams a range of key sectoral issues important to the Association\u2019s business community, as well as further avenues for cooperation. In particular, the discussion covered:<\/p>\n<ul>\n<li data-start=\"818\" data-end=\"1108\">The Ministry\u2019s plans for changes in the regulation of the medicines, medical devices and clinical trials markets, and continued cooperation with the Association;<\/li>\n<li data-start=\"818\" data-end=\"1108\">Systemic solutions to expand patient access to treatment, including a new co-payment mechanism for medicines within the reimbursement programme, synchronisation of price lists, planned expansion of the programme in 2027, and the practical impact of certain regulatory decisions adopted in 2025, such as the introduction of the National Price Catalogue;<\/li>\n<li data-start=\"818\" data-end=\"1108\">The impact of the proposed amendments to the Procedure for Conducting Clinical Trials on the availability of trials, and the need to develop a national strategy for the recovery and development of the clinical trials sector;<\/li>\n<li data-start=\"818\" data-end=\"1108\">European integration processes and institutional changes, including the establishment of a state supervisory authority and implementation of the new Law of Ukraine \u201cOn Medicinal Products\u201d;<\/li>\n<li data-start=\"818\" data-end=\"1108\">Anti-crisis instruments to ensure the resilience of pharmaceutical supply chains under wartime conditions, including the possibility of simplified import procedures, recognition of GMP certificates issued by regulatory authorities of countries with stringent control systems, and expanded opportunities for importers and distributors.<\/li>\n<\/ul>\n<p data-start=\"2395\" data-end=\"3043\">Representatives of the business community emphasised that, despite ongoing structured dialogue with the Ministry and joint efforts to ensure patient access to treatment during wartime, companies are increasingly experiencing a lack of regulatory predictability. Participants underlined the expectation of systemic reforms and the development of a modern regulatory framework that will ensure stable and transparent rules for the market \u2014 from the introduction of European approaches to regulatory procedures, the development of clinical trials and implementation of a national strategy in this area, to ensuring the continuity of medicine supply.<\/p>\n<p data-start=\"3045\" data-end=\"3599\">The business community also highlighted the importance of the practical implementation of the new legislation, the timely adoption of secondary legislation, and a transparent model for launching the new state supervisory authority, to be developed in partnership with the market and in line with European approaches. In the view of companies, predictable regulatory policy and high-quality legislative reform are key prerequisites for improving patient access to treatment and ensuring the resilience of the pharmaceutical system in wartime conditions.<\/p>\n<p data-start=\"3601\" data-end=\"3964\" data-is-last-node=\"\" data-is-only-node=\"\">The European Business Association expresses its sincere gratitude to the Minister and all colleagues for the open and constructive dialogue. The parties agreed to continue cooperation on the above issues. For its part, the Association remains ready to share its expertise and contribute to the development of effective solutions for the advancement of the sector.<\/p>\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>On 5 February, representatives of the European Business Association met with Viktor Liashko, Minister of Health of Ukraine; Edem Adamanov, newly appointed Director of the State Expert Centre of the Ministry of Health of Ukraine; Volodymyr Korolenko, Acting Head of the State Service of Ukraine on Medicines and Drugs Control; and their colleagues. The meeting [&hellip;]<\/p>\n","protected":false},"author":33544,"featured_media":714747,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false},"categories":[4,5,22],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Development priorities for the pharmaceutical market and clinical trials in Ukraine: meeting of the Health Care Committee Board with the leadership of the Ministry of Health - European Business Association<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/eba.com.ua\/priorytety-rozvytku-farmatsevtychnogo-rynku-ta-klinichnyh-doslidzhen-v-ukrayini-zustrich-pravlinnya-komitetu-z-ohorony-zdorov-ya-z-kerivnytstvom-moz\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Development priorities for the pharmaceutical market and clinical trials in Ukraine: meeting of the Health Care Committee Board with the leadership of the Ministry of Health - European Business Association\" \/>\n<meta property=\"og:description\" content=\"On 5 February, representatives of the European Business Association met with Viktor Liashko, Minister of Health of Ukraine; Edem Adamanov, newly appointed Director of the State Expert Centre of the Ministry of Health of Ukraine; Volodymyr Korolenko, Acting Head of the State Service of Ukraine on Medicines and Drugs Control; and their colleagues. The meeting [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/eba.com.ua\/priorytety-rozvytku-farmatsevtychnogo-rynku-ta-klinichnyh-doslidzhen-v-ukrayini-zustrich-pravlinnya-komitetu-z-ohorony-zdorov-ya-z-kerivnytstvom-moz\/\" \/>\n<meta property=\"og:site_name\" content=\"European Business Association\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-05T15:58:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-12T15:25:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/eba.com.ua\/wp-content\/uploads\/2026\/02\/WhatsApp-Image-2026-02-05-at-15.50.23.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"valeriia.diachok@eba.com.ua\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"valeriia.diachok@eba.com.ua\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/eba.com.ua\/priorytety-rozvytku-farmatsevtychnogo-rynku-ta-klinichnyh-doslidzhen-v-ukrayini-zustrich-pravlinnya-komitetu-z-ohorony-zdorov-ya-z-kerivnytstvom-moz\/\",\"url\":\"https:\/\/eba.com.ua\/priorytety-rozvytku-farmatsevtychnogo-rynku-ta-klinichnyh-doslidzhen-v-ukrayini-zustrich-pravlinnya-komitetu-z-ohorony-zdorov-ya-z-kerivnytstvom-moz\/\",\"name\":\"[:ua]\u041f\u0440\u0456\u043e\u0440\u0438\u0442\u0435\u0442\u0438 \u0440\u043e\u0437\u0432\u0438\u0442\u043a\u0443 \u0444\u0430\u0440\u043c\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u043d\u043e\u0433\u043e \u0440\u0438\u043d\u043a\u0443 \u0442\u0430 \u043a\u043b\u0456\u043d\u0456\u0447\u043d\u0438\u0445 \u0434\u043e\u0441\u043b\u0456\u0434\u0436\u0435\u043d\u044c \u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0456: \u0437\u0443\u0441\u0442\u0440\u0456\u0447 \u041f\u0440\u0430\u0432\u043b\u0456\u043d\u043d\u044f \u041a\u043e\u043c\u0456\u0442\u0435\u0442\u0443 \u0437 \u043e\u0445\u043e\u0440\u043e\u043d\u0438 \u0437\u0434\u043e\u0440\u043e\u0432\u2019\u044f \u0437 \u043a\u0435\u0440\u0456\u0432\u043d\u0438\u0446\u0442\u0432\u043e\u043c \u041c\u041e\u0417\u00a0[:en]Development priorities for the pharmaceutical market and clinical trials in Ukraine: meeting of the Health Care Committee Board with the leadership of the Ministry of Health[:] - European Business Association\",\"isPartOf\":{\"@id\":\"https:\/\/eba.com.ua\/#website\"},\"datePublished\":\"2026-02-05T15:58:59+00:00\",\"dateModified\":\"2026-03-12T15:25:09+00:00\",\"author\":{\"@id\":\"https:\/\/eba.com.ua\/#\/schema\/person\/afc2b62434325f60268e275c74c59dbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/eba.com.ua\/priorytety-rozvytku-farmatsevtychnogo-rynku-ta-klinichnyh-doslidzhen-v-ukrayini-zustrich-pravlinnya-komitetu-z-ohorony-zdorov-ya-z-kerivnytstvom-moz\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/eba.com.ua\/priorytety-rozvytku-farmatsevtychnogo-rynku-ta-klinichnyh-doslidzhen-v-ukrayini-zustrich-pravlinnya-komitetu-z-ohorony-zdorov-ya-z-kerivnytstvom-moz\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/eba.com.ua\/priorytety-rozvytku-farmatsevtychnogo-rynku-ta-klinichnyh-doslidzhen-v-ukrayini-zustrich-pravlinnya-komitetu-z-ohorony-zdorov-ya-z-kerivnytstvom-moz\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/eba.com.ua\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u041f\u0440\u0456\u043e\u0440\u0438\u0442\u0435\u0442\u0438 \u0440\u043e\u0437\u0432\u0438\u0442\u043a\u0443 \u0444\u0430\u0440\u043c\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u043d\u043e\u0433\u043e \u0440\u0438\u043d\u043a\u0443 \u0442\u0430 \u043a\u043b\u0456\u043d\u0456\u0447\u043d\u0438\u0445 \u0434\u043e\u0441\u043b\u0456\u0434\u0436\u0435\u043d\u044c \u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0456: \u0437\u0443\u0441\u0442\u0440\u0456\u0447 \u041f\u0440\u0430\u0432\u043b\u0456\u043d\u043d\u044f \u041a\u043e\u043c\u0456\u0442\u0435\u0442\u0443 \u0437 \u043e\u0445\u043e\u0440\u043e\u043d\u0438 \u0437\u0434\u043e\u0440\u043e\u0432\u2019\u044f \u0437 \u043a\u0435\u0440\u0456\u0432\u043d\u0438\u0446\u0442\u0432\u043e\u043c \u041c\u041e\u0417\u00a0\",\"item\":{\"@type\":\"WebPage\",\"name\":\"[:ua]\u041f\u0440\u0456\u043e\u0440\u0438\u0442\u0435\u0442\u0438 \u0440\u043e\u0437\u0432\u0438\u0442\u043a\u0443 \u0444\u0430\u0440\u043c\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u043d\u043e\u0433\u043e \u0440\u0438\u043d\u043a\u0443 \u0442\u0430 \u043a\u043b\u0456\u043d\u0456\u0447\u043d\u0438\u0445 \u0434\u043e\u0441\u043b\u0456\u0434\u0436\u0435\u043d\u044c \u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0456: \u0437\u0443\u0441\u0442\u0440\u0456\u0447 \u041f\u0440\u0430\u0432\u043b\u0456\u043d\u043d\u044f \u041a\u043e\u043c\u0456\u0442\u0435\u0442\u0443 \u0437 \u043e\u0445\u043e\u0440\u043e\u043d\u0438 \u0437\u0434\u043e\u0440\u043e\u0432\u2019\u044f \u0437 \u043a\u0435\u0440\u0456\u0432\u043d\u0438\u0446\u0442\u0432\u043e\u043c \u041c\u041e\u0417\u00a0[:en]Development priorities for the pharmaceutical market and clinical trials in Ukraine: meeting of the Health Care Committee Board with the leadership of the Ministry of Health[:]\"}}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/eba.com.ua\/#website\",\"url\":\"https:\/\/eba.com.ua\/\",\"name\":\"European Business Association\",\"description\":\"We are looking for proactive business leaders, who shape the investment climate of Ukraine and ready to supervise the work of the largest and the most influential business-community of Ukraine \u2013 European Business Association!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/eba.com.ua\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/eba.com.ua\/#\/schema\/person\/afc2b62434325f60268e275c74c59dbe\",\"name\":\"valeriia.diachok@eba.com.ua\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/eba.com.ua\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/30342c74f5ab2e8b43c7c40c44a7a4df?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/30342c74f5ab2e8b43c7c40c44a7a4df?s=96&d=mm&r=g\",\"caption\":\"valeriia.diachok@eba.com.ua\"},\"url\":\"https:\/\/eba.com.ua\/en\/author\/valeriia-diachok-eba-com-ua\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"[:ua]\u041f\u0440\u0456\u043e\u0440\u0438\u0442\u0435\u0442\u0438 \u0440\u043e\u0437\u0432\u0438\u0442\u043a\u0443 \u0444\u0430\u0440\u043c\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u043d\u043e\u0433\u043e \u0440\u0438\u043d\u043a\u0443 \u0442\u0430 \u043a\u043b\u0456\u043d\u0456\u0447\u043d\u0438\u0445 \u0434\u043e\u0441\u043b\u0456\u0434\u0436\u0435\u043d\u044c \u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0456: \u0437\u0443\u0441\u0442\u0440\u0456\u0447 \u041f\u0440\u0430\u0432\u043b\u0456\u043d\u043d\u044f \u041a\u043e\u043c\u0456\u0442\u0435\u0442\u0443 \u0437 \u043e\u0445\u043e\u0440\u043e\u043d\u0438 \u0437\u0434\u043e\u0440\u043e\u0432\u2019\u044f \u0437 \u043a\u0435\u0440\u0456\u0432\u043d\u0438\u0446\u0442\u0432\u043e\u043c \u041c\u041e\u0417\u00a0[:en]Development priorities for the pharmaceutical market and clinical trials in Ukraine: meeting of the Health Care Committee Board with the leadership of the Ministry of Health[:] - European Business Association","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/eba.com.ua\/priorytety-rozvytku-farmatsevtychnogo-rynku-ta-klinichnyh-doslidzhen-v-ukrayini-zustrich-pravlinnya-komitetu-z-ohorony-zdorov-ya-z-kerivnytstvom-moz\/","og_locale":"en_US","og_type":"article","og_title":"Development priorities for the pharmaceutical market and clinical trials in Ukraine: meeting of the Health Care Committee Board with the leadership of the Ministry of Health - European Business Association","og_description":"On 5 February, representatives of the European Business Association met with Viktor Liashko, Minister of Health of Ukraine; Edem Adamanov, newly appointed Director of the State Expert Centre of the Ministry of Health of Ukraine; Volodymyr Korolenko, Acting Head of the State Service of Ukraine on Medicines and Drugs Control; and their colleagues. The meeting [&hellip;]","og_url":"https:\/\/eba.com.ua\/priorytety-rozvytku-farmatsevtychnogo-rynku-ta-klinichnyh-doslidzhen-v-ukrayini-zustrich-pravlinnya-komitetu-z-ohorony-zdorov-ya-z-kerivnytstvom-moz\/","og_site_name":"European Business Association","article_published_time":"2026-02-05T15:58:59+00:00","article_modified_time":"2026-03-12T15:25:09+00:00","og_image":[{"width":1600,"height":1200,"url":"https:\/\/eba.com.ua\/wp-content\/uploads\/2026\/02\/WhatsApp-Image-2026-02-05-at-15.50.23.jpeg","type":"image\/jpeg"}],"author":"valeriia.diachok@eba.com.ua","twitter_card":"summary_large_image","twitter_misc":{"Written by":"valeriia.diachok@eba.com.ua","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/eba.com.ua\/priorytety-rozvytku-farmatsevtychnogo-rynku-ta-klinichnyh-doslidzhen-v-ukrayini-zustrich-pravlinnya-komitetu-z-ohorony-zdorov-ya-z-kerivnytstvom-moz\/","url":"https:\/\/eba.com.ua\/priorytety-rozvytku-farmatsevtychnogo-rynku-ta-klinichnyh-doslidzhen-v-ukrayini-zustrich-pravlinnya-komitetu-z-ohorony-zdorov-ya-z-kerivnytstvom-moz\/","name":"[:ua]\u041f\u0440\u0456\u043e\u0440\u0438\u0442\u0435\u0442\u0438 \u0440\u043e\u0437\u0432\u0438\u0442\u043a\u0443 \u0444\u0430\u0440\u043c\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u043d\u043e\u0433\u043e \u0440\u0438\u043d\u043a\u0443 \u0442\u0430 \u043a\u043b\u0456\u043d\u0456\u0447\u043d\u0438\u0445 \u0434\u043e\u0441\u043b\u0456\u0434\u0436\u0435\u043d\u044c \u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0456: \u0437\u0443\u0441\u0442\u0440\u0456\u0447 \u041f\u0440\u0430\u0432\u043b\u0456\u043d\u043d\u044f \u041a\u043e\u043c\u0456\u0442\u0435\u0442\u0443 \u0437 \u043e\u0445\u043e\u0440\u043e\u043d\u0438 \u0437\u0434\u043e\u0440\u043e\u0432\u2019\u044f \u0437 \u043a\u0435\u0440\u0456\u0432\u043d\u0438\u0446\u0442\u0432\u043e\u043c \u041c\u041e\u0417\u00a0[:en]Development priorities for the pharmaceutical market and clinical trials in Ukraine: meeting of the Health Care Committee Board with the leadership of the Ministry of Health[:] - European Business Association","isPartOf":{"@id":"https:\/\/eba.com.ua\/#website"},"datePublished":"2026-02-05T15:58:59+00:00","dateModified":"2026-03-12T15:25:09+00:00","author":{"@id":"https:\/\/eba.com.ua\/#\/schema\/person\/afc2b62434325f60268e275c74c59dbe"},"breadcrumb":{"@id":"https:\/\/eba.com.ua\/priorytety-rozvytku-farmatsevtychnogo-rynku-ta-klinichnyh-doslidzhen-v-ukrayini-zustrich-pravlinnya-komitetu-z-ohorony-zdorov-ya-z-kerivnytstvom-moz\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/eba.com.ua\/priorytety-rozvytku-farmatsevtychnogo-rynku-ta-klinichnyh-doslidzhen-v-ukrayini-zustrich-pravlinnya-komitetu-z-ohorony-zdorov-ya-z-kerivnytstvom-moz\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/eba.com.ua\/priorytety-rozvytku-farmatsevtychnogo-rynku-ta-klinichnyh-doslidzhen-v-ukrayini-zustrich-pravlinnya-komitetu-z-ohorony-zdorov-ya-z-kerivnytstvom-moz\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/eba.com.ua\/"},{"@type":"ListItem","position":2,"name":"\u041f\u0440\u0456\u043e\u0440\u0438\u0442\u0435\u0442\u0438 \u0440\u043e\u0437\u0432\u0438\u0442\u043a\u0443 \u0444\u0430\u0440\u043c\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u043d\u043e\u0433\u043e \u0440\u0438\u043d\u043a\u0443 \u0442\u0430 \u043a\u043b\u0456\u043d\u0456\u0447\u043d\u0438\u0445 \u0434\u043e\u0441\u043b\u0456\u0434\u0436\u0435\u043d\u044c \u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0456: \u0437\u0443\u0441\u0442\u0440\u0456\u0447 \u041f\u0440\u0430\u0432\u043b\u0456\u043d\u043d\u044f \u041a\u043e\u043c\u0456\u0442\u0435\u0442\u0443 \u0437 \u043e\u0445\u043e\u0440\u043e\u043d\u0438 \u0437\u0434\u043e\u0440\u043e\u0432\u2019\u044f \u0437 \u043a\u0435\u0440\u0456\u0432\u043d\u0438\u0446\u0442\u0432\u043e\u043c \u041c\u041e\u0417\u00a0","item":{"@type":"WebPage","name":"[:ua]\u041f\u0440\u0456\u043e\u0440\u0438\u0442\u0435\u0442\u0438 \u0440\u043e\u0437\u0432\u0438\u0442\u043a\u0443 \u0444\u0430\u0440\u043c\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u043d\u043e\u0433\u043e \u0440\u0438\u043d\u043a\u0443 \u0442\u0430 \u043a\u043b\u0456\u043d\u0456\u0447\u043d\u0438\u0445 \u0434\u043e\u0441\u043b\u0456\u0434\u0436\u0435\u043d\u044c \u0432 \u0423\u043a\u0440\u0430\u0457\u043d\u0456: \u0437\u0443\u0441\u0442\u0440\u0456\u0447 \u041f\u0440\u0430\u0432\u043b\u0456\u043d\u043d\u044f \u041a\u043e\u043c\u0456\u0442\u0435\u0442\u0443 \u0437 \u043e\u0445\u043e\u0440\u043e\u043d\u0438 \u0437\u0434\u043e\u0440\u043e\u0432\u2019\u044f \u0437 \u043a\u0435\u0440\u0456\u0432\u043d\u0438\u0446\u0442\u0432\u043e\u043c \u041c\u041e\u0417\u00a0[:en]Development priorities for the pharmaceutical market and clinical trials in Ukraine: meeting of the Health Care Committee Board with the leadership of the Ministry of Health[:]"}}]},{"@type":"WebSite","@id":"https:\/\/eba.com.ua\/#website","url":"https:\/\/eba.com.ua\/","name":"European Business Association","description":"We are looking for proactive business leaders, who shape the investment climate of Ukraine and ready to supervise the work of the largest and the most influential business-community of Ukraine \u2013 European Business Association!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/eba.com.ua\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/eba.com.ua\/#\/schema\/person\/afc2b62434325f60268e275c74c59dbe","name":"valeriia.diachok@eba.com.ua","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/eba.com.ua\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/30342c74f5ab2e8b43c7c40c44a7a4df?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/30342c74f5ab2e8b43c7c40c44a7a4df?s=96&d=mm&r=g","caption":"valeriia.diachok@eba.com.ua"},"url":"https:\/\/eba.com.ua\/en\/author\/valeriia-diachok-eba-com-ua\/"}]}},"_links":{"self":[{"href":"https:\/\/eba.com.ua\/en\/wp-json\/wp\/v2\/posts\/714746"}],"collection":[{"href":"https:\/\/eba.com.ua\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eba.com.ua\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eba.com.ua\/en\/wp-json\/wp\/v2\/users\/33544"}],"replies":[{"embeddable":true,"href":"https:\/\/eba.com.ua\/en\/wp-json\/wp\/v2\/comments?post=714746"}],"version-history":[{"count":1,"href":"https:\/\/eba.com.ua\/en\/wp-json\/wp\/v2\/posts\/714746\/revisions"}],"predecessor-version":[{"id":714751,"href":"https:\/\/eba.com.ua\/en\/wp-json\/wp\/v2\/posts\/714746\/revisions\/714751"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eba.com.ua\/en\/wp-json\/wp\/v2\/media\/714747"}],"wp:attachment":[{"href":"https:\/\/eba.com.ua\/en\/wp-json\/wp\/v2\/media?parent=714746"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eba.com.ua\/en\/wp-json\/wp\/v2\/categories?post=714746"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eba.com.ua\/en\/wp-json\/wp\/v2\/tags?post=714746"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}